Company / Shares Outstanding
AVADEL PHARMACEUTICALS PLC Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
95.1M
FY2024
5-year range
54.9M / 95.1M
FY2020-FY2024
Trend
+18.7%
vs FY2023
Sector context
#104 of 212
Health Care
What the data says
At 95141000.00, AVADEL PHARMACEUTICALS PLC's shares outstanding ranks #109 of 212 in the Health Care sector. Shares Outstanding has increased for 6 consecutive years, from 37325000.00 in FY2018 to 95141000.00 in FY2024.
Based on SEC 10-K filings.
95141000.00 in FY2024 with a 5-year CAGR of +20.5%.
Increased from 60094000.00 to 95141000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +20.5%
- 10-Year CAGR
- -
Sector benchmark
#109 of 212 in Health CareTop 51% of 212This company 95.1M Sector average 306.7M
▼
-69.0% below sector average
Key checks
Key Insights
- AVADEL PHARMACEUTICALS PLC's shares outstanding has grown for 6 consecutive years.
- In FY2024, shares outstanding increased 18.7% year-over-year.
- Ranks #104 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 95.1M | +18.7% |
| FY2023 | 80.2M | +33.4% |
| FY2022 | 60.1M | +2.7% |
| FY2021 | 58.5M | +6.5% |
| FY2020 | 54.9M | +46.9% |
| FY2019 | 37.4M | +0.2% |
| FY2018 | 37.3M | -10.6% |
| FY2017 | 41.8M | +1.3% |
| FY2016 | 41.2M | -5.4% |
| FY2015 | 43.6M | +20.4% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026